Decided to start buying back some $MSTR. I’ve been waiting since late December to begin accumulating, and I initially thought it would stay above $300, forcing me to jump back in.
Now that it's in an optimal buy area with enough confluence on the weekly timeframe, I’m accumulating under $250. I’ll add the last chunk once it breaks above $340.
Just keep in mind there’s a strong weekly downtrend in play, but it’s already hit the first target, so I expect a bounce. If it reclaims the POC at $340, it would invalidate the downtrend. So, I'm taking my chances on a possible invalidation and a continuation of the macro trend.
Now that it's in an optimal buy area with enough confluence on the weekly timeframe, I’m accumulating under $250. I’ll add the last chunk once it breaks above $340.
Just keep in mind there’s a strong weekly downtrend in play, but it’s already hit the first target, so I expect a bounce. If it reclaims the POC at $340, it would invalidate the downtrend. So, I'm taking my chances on a possible invalidation and a continuation of the macro trend.
Trade active
Waiting to add more sub $250
Note
added some here at $240Looks really bad but will give it some time.
Note
Needs to push higher, let's wait until Friday's close. 
MSTRNote
Was expecting a stronger move. Loses $270 and I will close it. Might have to come back on June/July
Trade closed manually
Loss $270. Will get back again once things consolidate...Taking the 15% for now.
Note
Great to see it moving back—watching for a new entry and will update soon! MSTRGood level to take some off as its back to the POC prior to the swing low.. $340
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.